AFJK 📈 Aimei Health Technology - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •
AFJK: Biopharmaceuticals, Medical Devices, Diagnostic Services
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Additional Sources for AFJK Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AFJK Stock Overview
| Market Cap in USD | 96m |
| Sector | Financial Services |
| Industry | Shell Companies |
| GiC Sub-Industry | Life Sciences Tools & Services |
| IPO / Inception | 2024-01-22 |
AFJK Stock Ratings
| Growth 5y | 51.3% |
| Fundamental | -25.6% |
| Dividend | - |
| Rel. Strength Industry | 1100 |
| Analysts | - |
| Fair Price Momentum | 9.86 USD |
| Fair Price DCF | - |
AFJK Dividends
No Dividends PaidAFJK Growth Ratios
| Growth Correlation 3m | 85% |
| Growth Correlation 12m | 98.5% |
| Growth Correlation 5y | 98.5% |
| CAGR 5y | 3.65% |
| CAGR/Mean DD 5y | 11.95 |
| Sharpe Ratio 12m | -0.28 |
| Alpha | -1.78 |
| Beta | 0.04 |
| Volatility | 7.77% |
| Current Volume | 2.4k |
| Average Volume 20d | 44.6k |
What is the price of AFJK stocks?
As of December 21, 2024, the stock is trading at USD 10.52 with a total of 2,400 shares traded.
Over the past week, the price has changed by -0.94%, over one month by -0.75%, over three months by +0.38% and over the past year by +3.65%.
As of December 21, 2024, the stock is trading at USD 10.52 with a total of 2,400 shares traded.
Over the past week, the price has changed by -0.94%, over one month by -0.75%, over three months by +0.38% and over the past year by +3.65%.
Is Aimei Health Technology a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Aimei Health Technology (NASDAQ:AFJK) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -25.63 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AFJK as of December 2024 is 9.86. This means that AFJK is currently overvalued and has a potential downside of -6.27%.
Probably not. Based on ValueRay Fundamental Analyses, Aimei Health Technology (NASDAQ:AFJK) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -25.63 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AFJK as of December 2024 is 9.86. This means that AFJK is currently overvalued and has a potential downside of -6.27%.
Is AFJK a buy, sell or hold?
Aimei Health Technology has no consensus analysts rating.
Aimei Health Technology has no consensus analysts rating.
What are the forecast for AFJK stock price target?
According to ValueRays Forecast Model, AFJK Aimei Health Technology will be worth about 10.7 in December 2025. The stock is currently trading at 10.52. This means that the stock has a potential upside of +1.24%.
According to ValueRays Forecast Model, AFJK Aimei Health Technology will be worth about 10.7 in December 2025. The stock is currently trading at 10.52. This means that the stock has a potential upside of +1.24%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 10.7 | 1.2% |